ALKBH5 and intervertebral disk degenerative disorder: Importantly, the inflammation microenvironment fails to induce IDD in both ALKBHKO and YTHDF1OE mice, suggesting that ALKBH5 and YTHDF1 hold potential as therapeutic targets for treating IDD patients with chronic inflammation.